menu
    • menu

    Company profile for Zai Lab

    NEW Drugs in Dev: 26
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Headquartered in Shanghai since our founding in 2014, our experienced team has secured partnerships with leading global biopharma companies, generating a broad and late-stage pipeli...
    Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U.S. focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Headquartered in Shanghai since our founding in 2014, our experienced team has secured partnerships with leading global biopharma companies, generating a broad and late-stage pipeline of innovative drug candidates. Based on our extensive track record of execution and delivering results.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zai LabChina Flag
    Country
    Country
    China
    Address
    Address
    Shanghai Building 1, 4/F Jinchuang Plaza 4560 Jinke Road Pudong, Shanghai
    Telephone
    Telephone
    +86 21 6163 2588
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.zailaboratory.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zai-lab/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zai Lab Shares Data on 3 In-House Oncology Drugs at AACR 2026
    Zai Lab Shares Data on 3 In-House Oncology Drugs at AACR 2026

    17 Mar 2026

    // BUSSINESSWIRE

    https://www.businesswire.com/news/home/20260317815099/en/Zai-Lab-to-Present-New-Data-on-Three-Internally-Developed-Oncology-Candidates-at-AACR-2026-Including-Zocilurtatug-Pelitecan-a-DLL3-Targeting-Antibody-Drug-Conjugate-ADC

    BUSSINESSWIRE
    17 Mar 2026
    Share Share
    Zai Lab To Unveil Q4 2025 Financials And Corporate Updates
    Zai Lab To Unveil Q4 2025 Financials And Corporate Updates

    10 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260210221858/en/Zai-Lab-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Recent-Corporate-Updates-on-February-26-2026

    BUSINESSWIRE
    10 Feb 2026
    Share Share
    Zai Lab Outlines Strategy, Global Pipeline at JPM 2026
    Zai Lab Outlines Strategy, Global Pipeline at JPM 2026

    13 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260113130363/en/Zai-Lab-Highlights-Strategic-Priorities-and-Global-Pipeline-Progress-at-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    13 Jan 2026
    Share Share
    Zai Lab Gets (NMPA) Nod For AUGTYRO In NTRK-Positive Solid Tumors
    Zai Lab Gets (NMPA) Nod For AUGTYRO In NTRK-Positive Solid Tumors

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106154296/en/Zai-Lab-Announces-National-Medical-Products-Administration-NMPA-Approval-of-AUGTYRO-repotrectinib-for-Patients-with-NTRK-Positive-Solid-Tumors

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Zai Lab To Present At J.P. Morgan Healthcare Conference
    Zai Lab To Present At J.P. Morgan Healthcare Conference

    05 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260105004446/en/Zai-Lab-to-Present-at-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    05 Jan 2026
    Share Share
    Zai Lab Gets China Approval For Cobenfy In Schizophrenia
    Zai Lab Gets China Approval For Cobenfy In Schizophrenia

    23 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251223179134/en/Zai-Lab-Announces-Approval-of-COBENFY-xanomeline-and-trospium-chloride-in-China-a-First-in-Class-Therapy-for-Schizophrenia

    BUSINESSWIRE
    23 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search